Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5703 Target Snapshot

Tyrosine-protein kinase Srms · SINGLE PROTEIN · Homo sapiens

1,189Compounds
169Assays
7Approved Drugs
622.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9H3Y6. Use UniProt Q9H3Y6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9H3Y6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein kinase Srms as ChEMBL target CHEMBL5703, mapped to UniProt Q9H3Y6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein kinase Srms
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5703
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9H3Y6
Tyrosine-protein kinase Srms
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein kinase Srms is the right protein anchor across sources, using UniProt Q9H3Y6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein kinase Srms
UniProt AccessionQ9H3Y6
Component TypeProtein
Sequence Length488 aa

Tyrosine-protein kinase Srms

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein kinase Srms, mapped to UniProt Q9H3Y6. Sequence length is 488 aa.

Mapped IDQ9H3Y6
Review nameTyrosine-protein kinase Srms
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

7
Approved
4
Phase III
7
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC5031.0
KI470.0
KD121.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5416410 9.2 Ki 0.631 Approved
CHEMBL1997617 8.2 Ki 6.31 Preclinical
CHEMBL4108687 8.1 IC50 8.0 Preclinical
CHEMBL4106978 8.04 IC50 9.1 Preclinical
CHEMBL5416410 7.89 Kd 13.0 Approved
CHEMBL4749037 7.85 IC50 14.0 Preclinical
CHEMBL4114929 7.8 IC50 16.0 Preclinical
CHEMBL1230609 7.75 Kd 18.0 Clinical
CHEMBL4076024 7.72 IC50 19.0 Preclinical
CHEMBL1230020 7.68 Kd 21.0 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
15
5.5
32
6.0
16
6.5
15
7.0
14
7.5
3
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

BOSUTINIB
CHEMBL288441
Approved 2012
DASATINIB
CHEMBL5416410
Approved 2006
Assay Landscape

Assay Landscape

169
Total Assays
49
Tested Compounds
2
Assay Types
Binding — 168 assays, 41 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 136 40 6.5
assay format 25 0
cell-based format 7 1 7.2
Functional — 1 assays, 49 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 49 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine